. 2006 Dec;2(12):883-885.

The Current Use of Proton-Pump Inhibitor Therapy in Clinical GI Practice

Affiliations

Philip O Katz. Gastroenterol Hepatol (N Y). 2006 Dec.

. 2006 Dec;2(12):883-885.

¹ Chair, Division of Gastroenterology Albert Einstein Medical Center Philadelphia, Penn.

No abstract available

Similar articles

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM, Breslin NP, Hyde DK, Buckley MJ, O'Morain CA. Lee JM, et al. Aliment Pharmacol Ther. 1999 Apr;13(4):489-96. doi: 10.1046/j.1365-2036.1999.00504.x. Aliment Pharmacol Ther. 1999. PMID: 10215733 Clinical Trial.
Lack of proton pump inhibitor trial prior to commencing therapy for eosinophilic esophagitis is common in the community.
Whitson MJ, Lynch KL, Yang YX, Metz DC, Falk GW. Whitson MJ, et al. Dis Esophagus. 2018 May 1;31(5). doi: 10.1093/dote/dox143. Dis Esophagus. 2018. PMID: 29293904
[Proton pump inhibitors when using clopidogrel: balance between necessity and disadvantages].
van der Elst K, Oortgiesen B, Kruik-Kollöffel W, Hoogendoorn M, Hofma S, van Roon E. van der Elst K, et al. Ned Tijdschr Geneeskd. 2019 May 24;163:D3363. Ned Tijdschr Geneeskd. 2019. PMID: 31166094 Dutch.
A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity?
Cryer B. Cryer B. Am J Gastroenterol. 2006 Apr;101(4):711-3. doi: 10.1111/j.1572-0241.2006.00508.x. Am J Gastroenterol. 2006. PMID: 16635218
Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM, Hindley CE. Scheiman JM, et al. Clin Ther. 2010 Apr;32(4):667-77. doi: 10.1016/j.clinthera.2010.04.009. Clin Ther. 2010. PMID: 20435236 Review.

1. Katz PO. Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure. Aliment Pharmacol Ther. 2005;22(3):31–38. - PubMed
1. Katz PO. Effectiveness of proton pump inhibitors: beyond cost. Rev Gastroenterol Disord. 2004;4(4):S8–S15. - PubMed
1. Miner P, Jr, Katz PO, Chen Y, Sostek M. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol. 2003;98:2616–2620. - PubMed
1. Katz PO, Tutuian R. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease. Best Pract Res Clin Gastroenterol. 2001;15:371–384. - PubMed